Semantic Scholar uses AI to extract papers important to this topic.
Purpose of review Combined hyperlipidemia (CHL) is a complex phenotype that is commonly encountered clinically and is often… Expand OBJECTIVE
This study evaluated the effect of a atorvastatin-fenofibrate combination on lipid profile, in comparison to each drug… Expand BACKGROUND
Combined hyperlipidemia (CH) is an increasingly prevalent risk factor for premature heart disease, and its treatment… Expand Combined hyperlipidemia (CHL) is characterized by a concomitant elevation of plasma levels of triglyceride-rich, very low density… Expand Hypertriglyceridaemia is a common metabolic disorder frequently found in patients with coronary heart disease. Numerous studies… Expand OBJECTIVE
The objective of this study was to evaluate the effects of daily dietary supplementation with 1.25 g or 2.5 g of… Expand Patients presenting combined hyperlipidemia (CHL) display an elevated risk of coronary heart disease. The atherogenic lipoprotein… Expand The effect of ciprofibrate treatment on the atherogenic profile of low-density lipoprotein (LDL) subspecies in combined… Expand We have previously reported decreased production rates of the major apolipoprotein B (apoB)-containing lipoproteins, very-low… Expand We investigated the metabolism of very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density… Expand